Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$263.84M$263.84Mderived+152.6% vs Q4 2024 Net Income-$328.49M-$328.49MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$319,748,000N/M Operating Cash Flowderived-$247,596,000N/M Free Cash Flowderived-$264,185,000N/M Margins · derivedOperating margin-121.2%+99.4 pt vs Q4 2024
Net margin-124.5%+101.0 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 19, 2026 · 50 d after period end